Skip to content
healthcare.dev

Deferoxamine mesylate

NDC 60505-6237, Deferoxamine mesylate, injection, powder, lyophilized, for solution, from Apotex Corp..

Product NDC
60505-6237
Status
Listed
Labeler
Apotex Corp.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207384
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6237 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFEROXAMINE MESYLATE2 g/1

Pharmacologic classes

Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
60505-6237-6605056237064 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c99553fb-3fae-b88a-6c2c-efa7520197f9

Use it

Look up 60505-6237 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6237 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-6237. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.